Owned by the Association for International Promotion & Study in Tumors (APSIT)
Proteolysis targeting chimeras (PROTACs) in cancer therapy
Exploitation of the protein degradation machinery as a therapeutic strategy to degrade oncogenic proteins is experiencing revolutionary advances with the development of proteolysis targeting chimeras (PROTACs)...